Tianjin Lisheng Pharmaceutical Co Ltd (002393) — Free Cash Flow Generation Index
Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a Free Cash Flow Generation Index of 0.93x as of December 2025. Free cash flow of CN¥267.70 Million represents 1% of operating cash flow (CN¥287.81 Million). See 002393 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tianjin Lisheng Pharmaceutical Co Ltd Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Tianjin Lisheng Pharmaceutical Co Ltd across 19 annual periods. Explore 002393 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Tianjin Lisheng Pharmaceutical Co Ltd (2007–2025)
Year-by-year Free Cash Flow Generation Index for Tianjin Lisheng Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Tianjin Lisheng Pharmaceutical Co Ltd (002393) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.92x | CN¥414.39 Million | CN¥451.85 Million | CN¥37.46 Million | ▲ +134.5% |
| 2024 | 0.39x | CN¥34.51 Million | CN¥88.26 Million | CN¥53.75 Million | ▼ -40.8% |
| 2023 | 0.66x | CN¥138.29 Million | CN¥209.51 Million | CN¥61.72 Million | ▼ -24.7% |
| 2022 | 0.88x | CN¥290.47 Million | CN¥331.38 Million | CN¥40.91 Million | ▲ +59.2% |
| 2021 | 0.55x | CN¥108.10 Million | CN¥196.34 Million | CN¥88.24 Million | ▲ +273.1% |
| 2020 | -0.32x | CN¥-24.29 Million | CN¥76.37 Million | CN¥100.66 Million | ▼ -148.0% |
| 2019 | 0.66x | CN¥177.87 Million | CN¥268.33 Million | CN¥90.46 Million | ▲ +85.1% |
| 2018 | 0.36x | CN¥58.26 Million | CN¥162.69 Million | CN¥104.43 Million | ▼ -50.3% |
| 2017 | 0.72x | CN¥129.16 Million | CN¥179.25 Million | CN¥50.09 Million | ▲ +243.7% |
| 2016 | 0.21x | CN¥36.40 Million | CN¥173.60 Million | CN¥137.20 Million | ▲ +741.7% |
| 2015 | -0.03x | CN¥-6.47 Million | CN¥198.13 Million | CN¥204.60 Million | ▲ +98.9% |
| 2014 | -3.02x | CN¥-218.41 Million | CN¥72.24 Million | CN¥290.65 Million | ▼ -3627.3% |
| 2013 | -0.08x | CN¥-23.49 Million | CN¥289.62 Million | CN¥313.11 Million | ▼ -177.1% |
| 2012 | 0.11x | CN¥26.38 Million | CN¥250.72 Million | CN¥224.35 Million | ▲ +145.2% |
| 2011 | -0.23x | CN¥-31.36 Million | CN¥134.58 Million | CN¥165.94 Million | ▼ -137.2% |
| 2010 | 0.63x | CN¥116.87 Million | CN¥186.55 Million | CN¥69.69 Million | ▼ -31.2% |
| 2009 | 0.91x | CN¥178.55 Million | CN¥196.14 Million | CN¥17.60 Million | ▲ +86.7% |
| 2008 | 0.49x | CN¥61.73 Million | CN¥126.59 Million | CN¥64.86 Million | ▼ -47.0% |
| 2007 | 0.92x | CN¥161.02 Million | CN¥174.94 Million | CN¥13.92 Million | — |